Moat
Moat — What Protects Yatsen, If Anything
1. Moat in One Page
Conclusion: Narrow moat — and most of it gets spent on marketing before it reaches the operating line.
Yatsen has two real, company-specific advantages that go beyond "the Chinese beauty industry is attractive." First, a 78.2% FY2025 gross margin — second-highest in the listed China beauty peer set, behind only Mao Geping at ~84%. That is genuine pricing power on the way out the factory door. Second, a credible R&D intensity (3.2% of revenue, 269 patents, 1,049 R&D staff, university and hospital labs) that is unusual for a brand often coded by the market as "Perfect Diary, the Douyin marketing brand." e.l.f. — the U.S. peer that trades 13× higher EV/Revenue — spends about 1% on R&D. Yatsen spends 3× as much.
But two things keep the moat narrow rather than wide. (i) The 78.2% gross margin is then eaten by a 66.3% selling and marketing ratio, more than double e.l.f.'s 24.7% and Mao Geping's 35%, leaving operating margin at -4.3%. Whatever brand pull Yatsen has built is not strong enough to lower the customer-acquisition tax. (ii) 84.9% of revenue is sold through Tmall, Douyin, RED, JD and mini-programs — channels Yatsen does not own, where take-rates and KOL commissions are set by platforms with more leverage than Yatsen has. A moat that depends on renting other people's traffic is a moat in the sense that a fortified tenant is hard to displace — but the landlord still sets the rent.
The strongest single piece of evidence the moat is real is the four-year, ~1,500 bps gross-margin expansion from 63.5% (FY2018) to 78.2% (FY2025), driven by discount discipline on hero SKUs (Biolip, Galenic No. 1 vitamin C, DR.WU mandelic-acid serum) and skincare-mix shift, not by accounting. The strongest single piece of evidence the moat is weak is that this gross-margin gain has not translated into operating profit because S&M intensity has been flat at 66–67% for two years running. The market is pricing 0.25× EV/Sales against a peer median of ~2.1× — that gap is the market's verdict on whether the moat reaches the cash line.
Moat rating: Narrow moat — Weakest link: Marketing intensity will not bend
Evidence strength (0–100)
Durability (0–100)
The thesis sits on one fragile assumption: that the skincare mix shift (53% in FY2025, growing +63.5% YoY) will pull S&M intensity below 60% over the next eight quarters. If S&M stays at 66%, the gross-margin advantage is structurally trapped and the moat is not investable at any normal multiple.
2. Sources of Advantage
A moat is a durable, company-specific reason a competitor cannot replicate Yatsen's economics. Below are every candidate moat source for Yatsen, the mechanism by which it could protect economics, and the proof quality of each. Terms are defined in plain English the first time used.
Reading the table: Of ten candidate moat sources, only brand pricing power and R&D / intangibles receive a Medium proof rating. Multi-brand breadth and scale on the DTC stack are real but unproven as advantages — peers do similar things with better margin discipline. Six of ten candidate sources receive Not proven.
3. Evidence the Moat Works
This section tests the alleged moat against actual outcomes. Evidence cited supports or refutes the moat — neither pre-selected to flatter the conclusion.
Net read: Three pieces of evidence support a moat (gross margin level, gross margin durability, R&D credibility). Three refute it (S&M intensity, operating margin gap, missing retention disclosure). Two are mixed (skincare mix shift, balance-sheet runway). The gap between "moat at the gross line" and "no moat at the operating line" is the entire investment debate — and explains why the market prices Yatsen at 0.25× EV/Sales while peers trade 2-5×.
4. Where the Moat Is Weak or Unproven
The shape of the chart is the moat critique. Yatsen has Mao Geping's gross margin and e.l.f.'s growth rate but neither company's discipline on selling expense. Mao Geping converts 84% gross margin into 20% operating margin with 35% S&M. Yatsen converts 78% gross margin into -4% operating margin with 66% S&M. The difference is ~31 percentage points of marketing intensity — the entire moat, spent on the ad auction.
Six specific weaknesses:
The moat is currently a "marketing tax" not a "pricing premium that flows through." Brand pull (the moat) exists at the gross margin level but evaporates at the operating line because Yatsen pays Tmall/Douyin/KOLs to keep that customer reaching the shopping basket. A true brand moat shows up as lower marketing intensity over time. Yatsen's has been flat at 66–67% for two years.
Repeat-purchase rate is not disclosed. The defining metric for whether a beauty brand has a real customer moat is cohort net revenue retention (how much a vintage of customers spends in year 2 vs year 1) and repeat purchase rate (% of customers who place a second order within 12 months). Yatsen has had eight years to disclose these. It has not. Companies with strong retention disclose it. Companies with weak or volatile retention do not.
84.9% of revenue is rented from platforms Yatsen does not control. Tmall, Douyin, RED, JD, mini-programs set the rules. A 200 bps platform take-rate hike on FY2025 revenue equals ~¥75M / ~$11M of margin loss. Yatsen has no offsetting channel power. Compare with multinationals (department stores, travel retail, owned counter networks) or with offline-heavy domestic peers — Yatsen has none of those hedges.
Perfect Diary is shrinking inside the company. Color cosmetics revenue grew +1.9% in FY2025 and fell 9.1% in Q4 2025. The brand that built the company is no longer the brand carrying the moat. Half of revenue (47%) is in a structurally pressured segment facing Douyin micro-brand fragmentation on the low end and Mao Geping prestige trade-up on the high end.
Multi-brand portfolio breadth has earned no premium in the market. Mao Geping (one brand, founder-coded prestige) trades at 5.44× EV/Revenue. Yatsen (six brands, color + skincare + prestige skincare) trades at 0.25×. The market's verdict on portfolio breadth is that complexity dilutes signal, not that it amplifies it. The thesis that "diversification reduces single-brand risk" is intellectually defensible but empirically rejected by the multiple.
Related-party purchases are growing. Inventory and services purchased from "controlled entities" rose from ¥211M (2023) to ¥372M (2025) — +76% in two years versus +26% group revenue across the same span — now ~9% of revenue routed through companies the founder also controls. This is not malfeasance evidence; it is governance-discretion evidence. It limits outside-investor visibility into the cost structure that the moat ultimately needs to defend.
The single fragile assumption: that the skincare mix shift mechanically pulls S&M intensity below 60%. If Yatsen has the same cost-per-acquisition structure for skincare customers as for color customers — and the company does not disclose cohort retention to suggest otherwise — the gross-margin gain compounds the revenue line but not the operating line. That is the bear case in one sentence.
5. Moat vs Competitors
Reading the positioning chart: Yatsen sits at the far right of the x-axis (gross margin in the top quartile) but at the bottom of the y-axis (operating margin negative, only Estee Lauder is worse and Estee Lauder is in a cyclical China trough). The empty diagonal between Yatsen's gross margin and operating margin is the moat's leak — every Chinese peer in the bubble field has converted similar gross margin to mid-teens operating margin. The question is whether Yatsen's S&M intensity is structurally higher (no moat at scale) or temporarily higher (moat just unrecognized by the cost line).
Peer-comparison confidence: Medium. Margins are well-disclosed; repeat-purchase rates are not disclosed for any China peer (industry norm), so a complete cohort-economics comparison cannot be built from public data.
6. Durability Under Stress
A moat only matters if it survives stress. Yatsen has already been stress-tested once — the Q1-2022 Perfect Diary crisis (-38.3% YoY revenue) — and the gross-margin advantage held. The next stress tests are below.
The Q1-2022 stress test is the only completed natural experiment for the Yatsen moat: revenue collapsed 38% YoY, gross margin held, the company stayed solvent, and skincare mix accelerated. The moat — such as it is — defended price, not volume. That is the right shape of a real moat (a moat means you keep margin in bad years; you may still lose volume). But the test repeated through 2026-2027 with Mao Geping and Proya at full attention is the harder test. The first time you defend a moat, the attackers are not yet organized. The second time, they are.
7. Where Yatsen Fits
The Yatsen moat is not company-wide. It is concentrated in two specific places:
(i) Premium dermo-skincare brands: Galenic (France-origin), DR.WU (Taiwan-origin), Eve Lom (UK-origin). These three brands carry roughly 53% of FY2025 revenue (skincare mix), grew +63.5% YoY, and operate at gross margins above 80%. They benefit from clinical / dermatology claim credibility, prestige price points (¥600-¥1,500), and lower repeat-cycle elasticity than mass color cosmetics. If a moat exists at Yatsen, it is here. R&D investment, CSO Jing Cheng's 17-year Estee Lauder APAC dermatology pedigree, and the university-hospital lab relationships all defend this segment.
(ii) Perfect Diary as a national-brand color-cosmetic platform. This is the founding brand and 47% of revenue. The moat here is weaker and decaying. Color grew +1.9% in FY2025 and fell 9.1% in Q4. The brand is squeezed between Douyin micro-brands on price and Mao Geping on prestige trade-up. Perfect Diary still has scale advantage on Tmall flagship and a recognizable brand voice, but it is best understood as a slowly-melting ice cube subsidizing the skincare pivot, not as an independent moat.
The other three brands — Little Ondine, Pink Bear, Abby's Choice — are positioning fillers in specific niches; useful for portfolio coverage, not durable on their own.
Implication for investors: Underwriting Yatsen as a moat investment means underwriting the prestige skincare segment specifically, not the company in aggregate. If the skincare segment continues to compound at 30%+ for 8-12 quarters and S&M intensity falls below 60%, the segment is the moat and the rest is option value. If skincare growth decelerates to <20% before S&M bends, the moat is unproven at scale.
8. What to Watch
The first moat signal to watch is the quarterly Selling & Marketing ratio. A sustained drop below 60% for two consecutive quarters would be the strongest single evidence that the gross-margin moat is reaching the operating line. Holding at 66% would leave the moat structurally trapped — a balance-sheet story rather than an earnings story.